Webinars

This webinar will educate on the opportunities and challenges of using Real World Evidence (RWE) in medical communications and publication planning. Multiple stakeholder perspectives including that of publication professionals, journal editors, RWE writers and consultants will be discussed.

In this webinar, learn how the Duke Heart Center launched a fully digital, decentralized clinical study leveraging Deloitte’s ConvergeHEALTH MyPath for Clinical platform powered by Amazon Web Services (AWS) to study the impact of COVID-19 on athletes’ heart health. Discover how this important study could give us insights into the impact of COVID on elite athletes, as well as the role that cloud based digital platforms can play to accelerate recruitment and improve retention and event ascertainment to augment the in-person visits that would have been required in the past.

In Healthcare, we’re data rich but insight poor. Health data exchange between departments, sites and companies is complicated by a lack of standardization that makes universal interpretation a huge challenge. However, if applied correctly, regulatory and technological changes might provide the opportunity to unlock the potential of data interoperability.

Having inherited a handful of drug cost-cutting final rules proposed by the Trump White House, the Biden Administration has put forward a series of its own drug pricing initiatives even as Congress is poised to act on legislation containing key drug cost- cutting policies relating to Medicare & drug prices more generally.

A bespoke learning framework created by the largest industry group of Launch Excellence Medicals Affairs experts from across the globe​

After participating in the Launch Excellence MasterClass program, participants should be better able to: Understand the expanding Medical Affairs leadership role in Launch Excellence and how Medical Affairs expertise should be leveraged throughout the process to maximize value Identify core components of a successful launch from a company and learn from external stakeholders’ preferences Demonstrate cross-functional collaboration and alignment on shared goals and expectations when working across internal and external stakeholder networks Supporting the optimization of tools, systems and processes to elevate organizational launch capabilities and readiness with clear roles and responsibilities for strategic and implementation objectives Address current real-world launch challenges driven by an accelerated shift to digital and remote working through case studies and live discussion

Join the College of Population Health for the third session in its new speaker series, Innovation in Personalized Medicine & Population Health. Multi-Cancer Early Detection (MCED) assays represent a new paradigm in cancer screening with the potential to deliver on the long-unfulfilled promise of earlier detection of many cancers with a single test. However, introducing such technology at scale has the potential to create new challenges for patients, providers, and health systems. In this session we will explore ways to translate technology into action and build your organization’s toolbox.

MDIC’s next Case for Quality collaborative community Virtual Forum is scheduled for December 8. The forum will provide the latest updates from CDRH and CfQcc working groups.

Hear from Clarify Health, Pfizer, Karius, Novo Nordisk, and Fibrogen about their use of on-demand precision insights to better understand patient cohorts, hyper-segment markets and HCPs, create data-driven value stories for payers, and assess the cost of care.

As more and more fields like health economics and outcomes research (HEOR) embrace the enormous potential of data science and become increasingly reliant on modern scientific computing tools, there is a deep need to still understand the foundation on which the capabilities of these modern computing tools rest, what “big data” can and cannot deliver and why, and how to realize a potential of machine learning methods for causal inference.

Medtech companies have long been burdened by inefficient communication between front office (sales) and back office (operations). In addition, disconnected siloes and manual processes create friction resulting in a poor customer experience. Examples may include slow contract turnaround times, a lack of visibility into contract performance, and missed sales opportunities. The end result is lost revenue.

On Friday, Dec 3rd, we will be hosting a webinar with ICER’s Executive Vice President and Chief Operating Officer Sarah Emond, MPP on the key conclusions of our “Fair Access” initiative.

The two-day Congress will provide an interactive, cutting edge, and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies, and concepts surrounding orphan drugs and rare diseases.

Join this interactive, evidence-based session to understand how your organization can benefit from improved patient outcomes.

AMCP conducted a Market Insights roundtable to discuss the effect of COVID-19 on the healthcare payer and PBM systems from a population health management perspective.

As health care challenges continue to evolve, population health management is front and center to help improve clinical outcomes through a variety of interventions. To help plan sponsors improve patient outcomes and reduce costs, pharmacy benefit managers (PBMs) are turning to evidence-based population health management programs, such as solutions for medication adherence, opioid abuse and pharmacogenomics.

Join us for a multi-stakeholder panel discussion following the release of the IQVIA Institute report on Drug Expenditure Dynamics 1995-2020: Understanding Medicine Spending in Context, which, for the first time, offers estimates of total drug spending, including hospitals and net of discounts and rebates across 11 countries.  The report also explains the drivers of change in drug expenditure over time and the dynamic composition by therapy area.

With unique perspective from the COVID-19 pandemic, this expert panel will discuss the effective use of telehealth and remote patient monitoring (RPM) to manage patient and population health.

National reimbursement for drugs is mainly regulated by the joint federal committee (G-BA) in Germany. However, when it comes to the management and organization of regional drug budgets and the controlling mechanisms the Association of Statutory Physicians (KVs) are a main stakeholder.

In this panel discussion, a collection of experts, each with a range of experience, provide their insights into industry use of real-world evidence and data (RWE/D). We will discuss topics such as how RWE is important to understand disease and the ease of generation.

Join other health care leaders for this 2-day online course to learn the “how to” of outcomes measurement, including where to start, what measures to use, how to calculate associated costs, and how to use the tools currently available. Tuition is $950.

This webinar will discuss why “just okay” communication doesn’t meet the needs of today’s consumers. Current patient & family communication technologies in use today. The history of the operating room and why historically there has been a lack of communication with patient families. The evolution and experience of the Vocera Ease solution.

During this presentation, the speakers will present a case for a common language and the need for a robust toolkit that supports planning and design of external control arms.

This HEOR theater session will highlight various real world insights into the US COVID-19 crisis derived from the analysis of claims data.

Now more than ever, HEOR and market access teams need to ensure they have a deep understanding of vaccine evaluation requirements to plan for success. During this presentation we will analyze the global requirements of NITAGs and HTA agencies for vaccine evaluation, and discuss how you can provide your team with the materials they need to demonstrate value.